Your browser doesn't support javascript.
loading
Seasonal variation in attacks of neuromyelitis optica spectrum disorders and multiple sclerosis: Evaluation of 794 attacks from a nationwide registry in Argentina.
Carnero Contentti, Edgar; Lopez, Pablo A; Pettinicchi, Juan Pablo; Criniti, Juan; Pappolla, Agustín; Miguez, Jimena; Patrucco, Liliana; Cristiano, Edgardo; Liwacki, Susana; Tkachuk, Verónica; Balbuena, María E; Vrech, Carlos; Deri, Norma; Correale, Jorge; Marrodan, Mariano; Ysrraelit, María C; Leguizamon, Felisa; Luetic, Geraldine; Menichini, María L; Tavolini, Darío; Mainella, Carolina; Zanga, Gisela; Burgos, Marcos; Hryb, Javier; Barboza, Andrés; Lazaro, Luciana; Alonso, Ricardo; Fernández Liguori, Nora; Nadur, Débora; Chercoff, Aníbal; Alonso Serena, Marina; Caride, Alejandro; Paul, Friedemann; Rojas, Juan I.
Afiliação
  • Carnero Contentti E; Department of Neurosciences, Neuroimmunology Unit, Hospital Alemán, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina. Electronic address: ecarnerocontentti@hospitalaleman.com.
  • Lopez PA; Department of Neurosciences, Neuroimmunology Unit, Hospital Alemán, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina.
  • Pettinicchi JP; Department of Neurosciences, Neuroimmunology Unit, Hospital Alemán, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina.
  • Criniti J; Department of Neurosciences, Neuroimmunology Unit, Hospital Alemán, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina.
  • Pappolla A; Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Miguez J; Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Patrucco L; Servicio de Neurología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Cristiano E; Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina.
  • Liwacki S; Clínica Universitaria Reina Fabiola, Córdoba, Argentina; Servicio de Neurología - Hospital Córdoba, Córdoba, Argentina.
  • Tkachuk V; Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina.
  • Balbuena ME; Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina.
  • Vrech C; Departamento de Enfermedades desmielinizantes - Sanatorio Allende, Córdoba, Argentina.
  • Deri N; Centro de Investigaciones Diabaid, CABA, Argentina.
  • Correale J; Departamento de Neurología - Fleni, CABA, Argentina.
  • Marrodan M; Departamento de Neurología - Fleni, CABA, Argentina.
  • Ysrraelit MC; Departamento de Neurología - Fleni, CABA, Argentina.
  • Leguizamon F; Hospital de Agudos, Dr. Teodoro Álvarez, CABA, Argentina.
  • Luetic G; Instituto de Neurociencias de Rosario, Santa Fe, Argentina.
  • Menichini ML; Sanatorio Británico, Rosario, Santa Fe, Argentina.
  • Tavolini D; INECO Neurociencias Oroño, Rosario, Santa Fe, Argentina.
  • Mainella C; Hospital Español de Rosario, Santa Fe, Argentina.
  • Zanga G; Unidad asistencial César Milstein, CABA, Argentina.
  • Burgos M; Servicio de Neurología - Hospital San Bernardo, Salta, Argentina.
  • Hryb J; Servicio de Neurología - Hospital Carlos G. Durand, CABA, Argentina.
  • Barboza A; Hospital Central de Mendoza, Mendoza, Argentina.
  • Lazaro L; Sanatorio Güemes, CABA, Argentina.
  • Alonso R; Sanatorio Güemes, CABA, Argentina.
  • Fernández Liguori N; Sanatorio Güemes, CABA, Argentina.
  • Nadur D; Sección de Neuroinmunología y Enfermedades Desmielinizantes, Servicio de Neurología - Hospital de Clínicas José de San Martín, CABA, Argentina; Hospital Naval, CABA, Argentina.
  • Chercoff A; Sección de Enfermedades Desmielinizantes - Hospital Británico, CABA, Argentina.
  • Alonso Serena M; Servicio de clínica médica, Hospital Italiano de Buenos Aires, CABA, Argentina.
  • Caride A; Department of Neurosciences, Neuroimmunology Unit, Hospital Alemán, Av. Pueyrredón 1640, Buenos Aires C1118AAT, Argentina.
  • Paul F; NeuroCure Clinical Research Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany; Experimental and Clinical Research Center, Max Delbrueck Center for Molecular Medicine and Charité -
  • Rojas JI; Centro de esclerosis múltiple de Buenos Aires, CABA, Argentina; Servicio de Neurología, Hospital Universitario de CEMIC, CABA, Argentina.
Mult Scler Relat Disord ; 58: 103466, 2022 Feb.
Article em En | MEDLINE | ID: mdl-34929456
ABSTRACT

BACKGROUND:

Identification of triggers that potentially instigate attacks in neuromyelitis optica spectrum disorders (NMOSD) and multiple sclerosis (MS) has remained challenging. We aimed to analyze the seasonality of NMOSD and MS attacks in an Argentinean cohort seeking differences between the two disorders.

METHODS:

A retrospective study was conducted in a cohort of NMOSD and MS patients followed in specialized centers from Argentina and enrolled in RelevarEM, a nationwide, longitudinal, observational, non-mandatory registry of MS/NMOSD patients. Patients with complete relapse data (date, month and year) at onset and during follow-up were included. Attack counts were analyzed by month using a Poisson regression model with the median monthly attack count used as reference.

RESULTS:

A total of 551 patients (431 MS and 120 NMOSD), experiencing 236 NMOSD-related attacks and 558 MS-related attacks were enrolled. The mean age at disease onset in NMOSD was 39.5 ± 5.8 vs. 31.2 ± 9.6 years in MS (p < 0.01). Mean follow-up time was 6.1 ± 3.0 vs. 7.4 ± 2.4 years (p < 0.01), respectively. Most of the included patients were female in both groups (79% vs. 60%, p < 0.01). We found a peak of number of attacks in June (NMOSD 28 attacks (11.8%) vs MS 33 attacks (5.9%), incidence rate ratio 1.82, 95%CI 1.15-2.12, p = 0.03), but no differences were found across the months in both disorders when evaluated separately. Strikingly, we observed a significant difference in the incidence rate ratio of attacks during the winter season when comparing NMOSD vs. MS (NMOSD 75 attacks (31.7%) vs MS 96 attacks (17.2%), incidence rate ratio 1.82, 95%CI 1.21-2.01, p = 0.02) after applying Poisson regression model. Similar results were observed when comparing the seropositive NMOSD (n = 75) subgroup vs. MS.

CONCLUSIONS:

Lack of seasonal variation in MS and NMOSD attacks was observed when evaluated separately. Future epidemiological studies about the effect of different environmental factors on MS and NMOSD attacks should be evaluated prospectively in Latin America population.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do sul / Argentina Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neuromielite Óptica / Esclerose Múltipla Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans País/Região como assunto: America do sul / Argentina Idioma: En Ano de publicação: 2022 Tipo de documento: Article